LAVA Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Jan 1, 2020
Market Capitalization	54	42	92	142	-	-
Market Cap Growth	100.60%	-54.86%	-35.10%	-	-	-
Enterprise Value	-41	-57	4	4	-	-
Last Close Price	3.33	1.58	3.50	5.50	-	-
PE Ratio	-	-0.91	-2.66	-2.26	-	-
PS Ratio	4.03	5.55	4.44	23.30	-	-
PB Ratio	1.00	0.73	1.00	1.05	-	-
P/FCF Ratio	-2.53	-0.95	24.91	-4.24	-	-
P/OCF Ratio	-2.55	-0.96	21.29	-4.35	-	-
EV/Sales Ratio	-0.13	-7.60	0.19	0.71	-	-
EV/EBITDA Ratio	0.05	1.21	-0.11	-0.09	-	-
EV/EBIT Ratio	0.05	1.19	-0.11	-0.09	-	-
EV/FCF Ratio	0.05	1.30	1.06	-0.13	-	-
Debt / Equity Ratio	0.12	0.12	0.06	0.04	0.54	0.30
Debt / FCF Ratio	-0.19	-0.16	1.58	-0.17	-0.42	-0.19
Asset Turnover	0.11	0.06	0.14	0.07	0.26	-
Quick Ratio	7.33	6.51	6.20	11.91	2.36	5.31
Current Ratio	7.42	6.62	6.40	12.14	2.48	5.35
Return on Equity (ROE)	-45.40%	-61.18%	-31.22%	-67.24%	-236.57%	-
Return on Assets (ROA)	-16.89%	-22.06%	-15.41%	-34.13%	-62.63%	-
Return on Capital (ROIC)	-28.47%	-36.29%	-20.28%	-40.40%	-94.97%	-
Earnings Yield	-56.56%	-111.70%	-37.06%	-33.98%	-	-
FCF Yield	-63.07%	-105.65%	4.01%	-23.59%	-	-
Buyback Yield / Dilution	-1.92%	-3.12%	-31.21%	-4850.36%	10.81%	-
Total Shareholder Return	-1.92%	-3.12%	-31.21%	-4850.36%	10.81%	-

Source: S&P Capital IQ. Standard template.